Venmax Drugs & Pharmaceuticals has been directed by the National Company Law Tribunal to convene an equity shareholder meeting regarding its proposed amalgamation with Hatri Pharma Private Limited. The tribunal issued the order on September 7, 2026, setting the stage for the next procedural step in the corporate restructuring process.

The National Company Law Tribunal, Hyderabad Bench, scheduled the meeting for Saturday, October 24, 2026, at 12:30 p.m. The session will be conducted through video conference or other audio-visual means, ensuring remote accessibility for shareholders. This directive follows the disposal of Case Application CA (CAA) 30/230/HDB/2026, which was heard before Judicial Member Rajeev Bhardwaj and Technical Member Sanjay Puri.

Scheme Details

The amalgamation falls under sections 230 to 232 of the Companies Act, 2013. Hatri Pharma Private Limited is designated as the amalgamating company, while Venmax Drugs serves as the amalgamated company. The tribunal’s order allows and disposes of the case application, mandating the convening of the shareholder meeting as a critical compliance step.

Venmax Drugs disclosed this development to the BSE Limited on September 8, 2026, citing SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company confirmed that the order copy and related documents are available on its official website for stakeholder reference.

What the Numbers Show

While no financial figures were disclosed in this specific regulatory filing, the progression to a shareholder vote indicates regulatory approval of the scheme’s structural validity. The timeline sets a clear deadline for investor engagement, with the October 24 meeting serving as the final approval gate before implementation.

Venmax Drugs & Pharmaceuticals approved its 37th Annual General Meeting (AGM) notice and key director appointments during a board meeting on August 31, 2026. The company will hold the AGM via video conferencing on September 26, 2026.

The board approved the Notice, Directors Report, and Annual Report for FY26. It also cleared the Secretarial Audit Report issued by M/S Kashinath Sahu & Co.

Director Appointments

The board recommended three key governance changes for shareholder approval at the AGM:

• Venkata Rao Sadhanala: Designation changed from Whole-Time Director to Managing Director for five years, effective March 11, 2026. His remuneration is set at ₹30 lakh per annum including perquisites.
• Padmaja Kalyani Sadhanala: Regularized as Non-Executive Non-Independent Director from March 30, 2026. She receives no managerial remuneration.
• Revoor Ramachandra: Regularized as Non-Executive Independent Director for a five-year term from March 30, 2026. He also receives no managerial remuneration.

AGM Logistics

Shareholders can vote electronically via the CDSL E-Voting Platform. Remote e-voting runs from September 23 to September 25, 2026. The cut-off date for voting eligibility is September 18, 2026.

The Register of Members and Share Transfer Books remain closed from September 18 to September 26, 2026. M/s Kashinath Sahu & Co. has been appointed as the scrutinizer for the e-voting process.